摘要
目的:研究转化生长因子TGF-β2对体外培养人角膜内皮细胞(HCEC)增殖的影响机制。方法:体外培养经血清饥饿法获得同步化的HCEC,用不同浓度TGF-β2对HCEC进行不同时间的处理,采用细胞计数、MTT染色以及流式细胞仪(FCM)和RealtimePCR检测TGF-β2对HCEC的增殖、细胞周期及细胞中p27kip1和p21cip1表达的影响。结果:TGF-β21~15μg/L对HCEC有显著的增殖抑制作用,具有浓度和时间依赖性,9μg/L是TGF-β2抑制HCEC细胞增殖的峰浓度。9μg/LTGF-β2处理后,处于G1/G0期HCEC数量显著增加,并具有时间依赖性。9μg/LTGF-β2处理24h后,p27kip1表达量显著增加,48h后p27kip1和p21cip1的表达量均显著增加,也具有时间依赖性。结论:TGF-β2对HCEC具有显著的浓度和时间依赖性增殖抑制作用,可能通过先后诱导p27kip1和p21cip1表达量的增加将细胞拘留在G1/G0期来实现的。
AIM: To investigate the ability of Thymosin β4 (Tβ4) to promote healing in an alkali injury model in vivo and the mechanisms involved in that process which Tβ4 may be a potential anti-inflammation agent in this model.
METHODS: Corneas of the New-Zealand Rabbit were chemically burned with a 6mm disc soaked in 1mol/L NaOH for 30 seconds. Eyes were irrigated copiously with saline and then treated topically with PBS(Negative control group), rh-EGF(jinyinshu drop, Positive control group), and Tβ4 (0.1, 1, 10μg/50μL) twice daily. At the time point of 1 day, 3, 7, 14 days postburn, the healing rate of the cornea were examined and MMP-2, TIMP-2, VEGF immunostaining performed.
RESULTS:Tβ4-treated corneas demonstrated improved cornea healing rate of 33.8% vs PBS-treated corneas of 22.8%(P〈0.01) , 1μg/50μL Tβ4 seemed to be the best dosage. Whereas immunohistochemistry result suggested that Tβ4 decreased corneal NF-κB expression(P〈0.01) after alkali injury, no change in IL( interleukin) -1β was detected(P〉0.05). The enzyme linked immunosorbent assay (ELISA) result suggested that theres a significant decrease to the NF-κB protein levels(P〈0.01).
CONCLUSION: Tβ4 treatment decreases corneal inflammation and inhibits the expression of NF-κB to improve cornea healing. The result have important clinical implications for the potential role of Tβ4 as a corneal anti-inflammatory agent.
出处
《国际眼科杂志》
CAS
2010年第5期841-843,共3页
International Eye Science
基金
中国国家高技术研究发展863计划资助项目(No.2006AA02A132)~~